Mitochondrial DNA Copy Number and Risk of Diabetes Mellitus and Metabolic Syndrome

Context Mitochondrial DNA (mtDNA) plays a key role in diabetes mellitus and metabolic syndrome (MetS). An increasing number of studies have reported the association between mtDNA copy number (mtDNA-CN) and the risk of diabetes mellitus and MetS; however, the associations remain conflicted and a systematic review and meta-analysis on the association between mtDNA-CN and diabetes mellitus and MetS is lacking. Objective We aimed to investigate the association of mtDNA-CN and diabetes mellitus and MetS using a systematic review and meta-analysis of observational studies. Methods PubMed, EMBASE, and Web of Science were searched up to December 15, 2022. Random-effect models were used to summarize the relative risks (RRs) and 95% CIs. Results A total of 19 articles were included in the systematic review and 6 articles (12 studies) in the meta-analysis involving 21 714 patients with diabetes (318 870 participants) and 5031 MetS (15 040 participants). Compared to the highest mtDNA-CN, the summary RR (95% CIs) for the lowest mtDNA-CN were 1.06 (95% CI, 1.01-1.12; I-2 = 79.4%; n = 8) for diabetes (prospective study: 1.11 (1.02-1.21); I-2 = 22.6%; n = 4; case-control: 1.27 (0.66-2.43); I-2 = 81.8%; n = 2; cross-sectional: 1.01 (0.99-1.03); I-2 = 74.7%; n = 2), and 1.03 (0.99-1.07; I-2 = 70.6%; n = 4) for MetS (prospective: 2.87 (1.51-5.48); I-2 = 0; n = 2; cross-sectional: 1.02 (1.01-1.04); I-2 = 0; n = 2). Conclusion Decreased mtDNA-CN was associated with increased risk of diabetes mellitus and MetS when limited to prospective studies. More longitudinal studies are warranted.

Automated summary

Through a systematic review and meta-analysis, we found an association between mitochondrial DNA copy number and diabetes mellitus and metabolic syndrome. Lower copy numbers were associated with increased risk of diabetes mellitus and metabolic syndrome.